Company Overview
Snapshot
Founded in January 2019 by Tal Atarot, NimBio operates with 1–10 employees. The company has raised $1.37M across three funding rounds from two investors. In November 2024, NimBio was recognized as one of Europe's thirty most promising life science and healthtech startups.
Business overview
NimBio is developing non-invasive technology for the early detection of inflammation in chronic inflammatory diseases. Its core product, the Inflammometer™, is an AI-powered solution designed to passively collect real-time data from everyday devices like smartwatches or fitness bands. This technology aims to identify early signs of inflammation before a flare begins, thereby reducing hospitalizations and complications through timely treatment optimization. NimBio operates within the Health Tech & Life Sciences sector, specifically focusing on digital healthcare, patient remote monitoring, and medical decision support.
Strategic signal
In November 2024, NimBio was recognized among the top thirty most promising life science and healthtech startups in Europe. This acknowledgment signals strong validation of NimBio's innovative approach to chronic inflammatory disease management and highlights its potential for significant impact within the European healthcare market, attracting further investor and partnership interest.
Log in to access full profile ›Company Intelligence Q&A
- What is NimBio's core technology?
- NimBio develops the Inflammometer™, an AI-powered, non-invasive technology designed to detect early signs of inflammation in real time for chronic inflammatory diseases. This technology can be integrated into everyday devices like smartwatches or fitness bands.
- When was NimBio founded and by whom?
- NimBio was founded in January 2019 by Tal Atarot.
- Has NimBio received any recent industry recognition?
- Yes, in November 2024, NimBio was recognized as one of the thirty most promising life science and healthtech startups in Europe.
- Which investors have participated in NimBio's funding rounds?
- eHealth Ventures has participated in multiple funding rounds for NimBio, including a lead investment in November 2022. The Israel Innovation Authority also invested in September 2019.
- What is the total capital raised by NimBio?
- NimBio has raised a total of $1.37M across three funding rounds.